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Abstract
Background
With no effective treatments for cognitive decline or dementia, improving the evidence base
for modifiable risk factors is a research priority. This study investigated associations
between risk factors and late-life cognitive decline on a global scale, including comparisons
between ethno-regional groups.
Methods and findings
We harmonized longitudinal data from 20 population-based cohorts from 15 countries over
5 continents, including 48,522 individuals (58.4% women) aged 54–105 (mean = 72.7)
years and without dementia at baseline. Studies had 2–15 years of follow-up. The risk fac-
tors investigated were age, sex, education, alcohol consumption, anxiety, apolipoprotein E
ε4 allele (APOE*4) status, atrial fibrillation, blood pressure and pulse pressure, body mass
index, cardiovascular disease, depression, diabetes, self-rated health, high cholesterol,
hypertension, peripheral vascular disease, physical activity, smoking, and history of stroke.
Associations with risk factors were determined for a global cognitive composite outcome
(memory, language, processing speed, and executive functioning tests) and Mini-Mental
State Examination score. Individual participant data meta-analyses of multivariable linear
mixed model results pooled across cohorts revealed that for at least 1 cognitive outcome,
age (B = −0.1, SE = 0.01), APOE*4 carriage (B = −0.31, SE = 0.11), depression (B = −0.11,
SE = 0.06), diabetes (B = −0.23, SE = 0.10), current smoking (B = −0.20, SE = 0.08), and
history of stroke (B = −0.22, SE = 0.09) were independently associated with poorer cognitive
Determinants of cognition in diverse ethno-regional groups
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performance (p < 0.05 for all), and higher levels of education (B = 0.12, SE = 0.02) and vigor-
ous physical activity (B = 0.17, SE = 0.06) were associated with better performance (p <
0.01 for both). Age (B = −0.07, SE = 0.01), APOE*4 carriage (B = −0.41, SE = 0.18), and
diabetes (B = −0.18, SE = 0.10) were independently associated with faster cognitive decline
(p < 0.05 for all). Different effects between Asian people and white people included stronger
associations for Asian people between ever smoking and poorer cognition (group by risk
factor interaction: B = −0.24, SE = 0.12), and between diabetes and cognitive decline (B =
−0.66, SE = 0.27; p < 0.05 for both). Limitations of our study include a loss or distortion of
risk factor data with harmonization, and not investigating factors at midlife.
Conclusions
These results suggest that education, smoking, physical activity, diabetes, and stroke are all
modifiable factors associated with cognitive decline. If these factors are determined to be
causal, controlling them could minimize worldwide levels of cognitive decline. However, any
global prevention strategy may need to consider ethno-regional differences.
Author summary
Why was this study done?
• There is a growing global burden associated with cognitive decline and dementia.
• Evidence for modifiable risk factors that could be targeted to reduce this burden needs
to be improved.
• Risk factors for cognitive decline and dementia might differ between ethno-regional
groups.
What did the researchers do and find?
• We analyzed cognitive performance and risk factor data from 48,522 older individuals,
provided by 20 studies of aging representing 15 countries (Australia, Brazil, Cuba,
France, Germany, Greece, Hong Kong, Italy, Japan, Singapore, Spain, South Korea, The
Netherlands, the United Kingdom, and the United States). Cognitive performance was
measured as Mini-Mental State Examination (MMSE) and global cognition scores.
• When controlling for confounding risk factors, the apolipoprotein E ε4 allele
(APOE�4), depression, diabetes, current smoking, and history of stroke were associated
with poorer cognitive performance, and higher levels of education and vigorous physical
activity were associated with better performance. Age, APOE�4, and diabetes were asso-
ciated with faster cognitive decline.
• Compared to white people, Asian people showed stronger associations between having
ever smoked and cognitive performance, and between diabetes and cognitive decline.
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What do these findings mean?
• Modifiable risk factors associated with cognitive decline include education, smoking,
physical activity, diabetes, and stroke.
• If these associations are determined to be causal, interventions targeting these factors
may help reduce the global burden of cognitive decline and dementia.
• Interventions may require tailoring to particular ethno-regional groups.
Introduction
Whether a normal aspect of the aging process or a consequence of neuropathological changes
arising from many possible causes, cognitive decline is almost invariably associated with grow-
ing old [1,2]. The world’s population is aging rapidly, and with no effective therapies, the
global financial and societal burdens of cognitive decline are set to rise. Modifiable risk factors
for cognitive decline offer means to intervene and prevent or delay these rising global burdens.
However, the evidence base for associations between modifiable risk factors and cognitive
decline remains poor, and improving this is a research priority [1,3].
This study aims to improve the understanding of associations between risk factors and late-
life cognitive performance and decline. The first of 3 distinctive features of this study is a com-
prehensive examination of risk factors, with a large range of demographic, medical, lifestyle,
and physical and mental health factors investigated. Second is the global scale, with data
obtained from 20 population-based cohorts from 15 countries across 5 continents. Third is the
use of individual participant data (IPD), which has advantages over aggregate approaches,
including the ability to standardize analyses across samples and to adjust for confounding fac-
tors [4]. Having previously identified faster rates of cognitive decline in Asian people than in
white people [5], we also investigate whether the effects of risk factors differ between Asian
people and white people in this analysis. This study was done to identify and further assess risk
factors for poorer cognitive performance and decline in late life, and to determine whether
associations between particular factors and cognition are global.
Methods
Contributing studies
All 20 contributing cohorts were population-based and members of the Cohort Studies of
Memory in an International Consortium (COSMIC) collaboration [6], and are detailed in
Table 1. Fourteen of these cohorts were included in our previous report on cognitive decline
[5]. The additional 6 cohorts included in this study are CHAS, LEILA75+, MAAS, MoVIES,
SALSA, and Tajiri, which expand the number of countries covered by 3 (Cuba, Germany, and
The Netherlands) and increase the representation of Latin Americans and North American
Hispanics. Full cohorts were generally not used, as we excluded individuals with dementia at
baseline or who were missing age, sex, education, or dementia status data (typically less than
1%; S1 and S2 Tables). The cohorts had various assessment schedules (2–16 waves) and fol-
low-up durations (2–15 years; S3 Table). This project was approved by the University of New
South Wales Human Research Ethics Committee (HC 12446 and HC 17292). The contributing
cohorts had prior ethics approval (S4 Table). This study is reported as per the Strengthening
Determinants of cognition in diverse ethno-regional groups
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Abbreviations: APOE �4, apolipoprotein E ε4 allele;
BMI, body mass index; COSMIC, Cohort Studies of
Memory in an International Consortium; IPD,
individual participant data; MMSE, Mini-Mental
State Examination; SD, standard deviation; SE,
standard error.
the Reporting of Observational Studies in Epidemiology (STROBE) guideline (S1 Checklist),
and the prospective analysis plan is provided as S1 Text.
Measures
All cohorts provided age and sex data. Educational attainment was provided as years in full-
time education or converted to this from categorical data (S5 Table).
Our first cognitive outcome measure was a brief global cognitive or screening test: the
Mini-Mental State Examination (MMSE) [27] in 16 cohorts (the 4 exceptions are detailed in
S6 Table). The second measure was a global cognition composite score, calculated from 4
neuropsychological tests, each representing 1 of 4 cognitive domains. Cohorts varied in the
neuropsychological tests administered, so for each domain we used a single common test or
Table 1. Contributing studies (in alphabetical order).
Study Abbreviation Location Main race/ethnicity Years
runa
Reference
Bambui Cohort Study of Ageing Bambui Bambui, Brazil Brazilian 1997–
2013
Lima-Costa et al. [7]
Cognitive Function & Ageing Study CFAS United Kingdomb White 1989– Brayne et al. [8]
Cuban Health and Alzheimer Study CHAS Havana and Matanzas, Cuba White, black, mixedc 2003– Llibre-Rodriguez et al.
[9]
Einstein Aging Study EAS New York, US White, blackd 1993– Katz et al. [10]
Etude Sante´ Psychologique Pre´valence Risques et
Traitement
ESPRIT Montpellier, France White 1999– Ritchie et al. [11]
Hellenic Longitudinal Investigation of Aging and Diet HELIAD Larissa and Marousi, Greece White 2010– Dardiotis et al. [12]
Hong Kong Memory and Ageing Prospective Study HK-MAPS Hong Kong Chinese 2005– Wong et al. [13]
Invecchiamento Cerebrale in Abbiategrasso Invece.Ab Abbiategrasso, Italy White 2010–
2015
Guaita et al. [14]
Korean Longitudinal Study on Cognitive Aging and
Dementia
KLOSCAD South Korea (nationwide) Korean 2009–
2018
Han et al. [15]
Leipzig Longitudinal Study of the Aged LEILA75+ Leipzig, Germany White 1997–
2014
Riedel-Heller et al.
[16]
Maastricht Aging Studye MAAS South Limburg, The
Netherlands
White 1993–
2018
Jolles et al. [17]
Monongahela Valley Independent Elders Survey MoVIES Mid-Monongahela Valley, PA,
US
White 1987–
2002
Ganguli et al. [18]
Personality and Total Health Through Life Project PATH Canberra, Australia White 2001– Anstey et al. [19]
Sacramento Area Latino Study on Aging SALSA Sacramento area, CA, US Hispanic, Mexican
ancestry
1998–
2008
Haan et al. [20]
São Paulo Ageing & Health Study SPAH São Paulo, Brazil Brazilian 2003–
2008
Scazufca et al. [21]
Sasaguri Genkimon Study SGS Sasaguri, Japan Japanese 2011– Narazaki et al. [22]
Singapore Longitudinal Ageing Studies (I) SLASI Singapore Chinese 2003– Feng et al. [23]
Sydney Memory and Ageing Study Sydney MAS Sydney, Australia White 2005– Sachdev et al. [24]
Tajiri Project Tajiri Tajiri, Japan Japanese 1998–
2005
Meguro et al. [25]
Zaragoza Dementia Depression Project ZARADEMP Zaragoza, Spain White 1994– Lobo et al. [26]
aStudies without an end date are ongoing.
bFive identical centers including Cambridgeshire, Gwynedd, Newcastle, Nottingham, and Oxford.
cWhite 72.4%, black 16.5%, mixed 11.0%.
dWhite 66.5%, black 27.6%.
eOnly participants aged 55 years or more at baseline were included.
https://doi.org/10.1371/journal.pmed.1002853.t001
Determinants of cognition in diverse ethno-regional groups
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type: delayed word list recall for memory, semantic fluency for language, and Trail Making
Test A and B for processing speed and executive functioning, respectively (S6 Table).
The baseline factors investigated were age, sex, education, current alcohol consumption
(nil/minimal, 1 drink/week, 2+ drinks/week), anxiety, apolipoprotein E ε4 allele (APOE�4)
carriage (having at least 1 ε4 allele), atrial fibrillation, blood pressure and pulse pressure, body
mass index (BMI), cardiovascular disease, depression (both current and history of), diabetes,
health (self-reported: very good, good, or poor), high cholesterol (either total cholesterol or tri-
glycerides), hypertension, peripheral vascular disease, physical activity (minimal, or moderate
or vigorous at least once a week), smoking (never, past, current), and history of stroke. For
some of these factors, while particular levels may be considered as increasing risk, others may
be considered as protective. For simplicity we refer to all of the factors investigated as risk fac-
tors. Most cohorts lacked data for some factors (S7 Table). The available data for some factors
were comparable across the contributing studies as presented (APOE�4, BMI, blood pressure
and pulse pressure, and smoking). Other factors required harmonization because the type and
number of measures for these varied across the studies. For binary medical and mental health
condition variables (anxiety, current depression, history of depression, hypertension, diabetes,
high cholesterol, peripheral vascular disease, atrial fibrillation, cardiovascular disease, and
stroke), we used all available information from a study relevant to diagnosing or classifying the
condition. For example, in a study with limited information, hypertension may be classified
only from a medical history record, while for another study, it may be indicated by any of self-
reported history, use of relevant medication, or measured blood pressure exceeding values
indicated by international guidelines. Some factors required further work to harmonize,
including the transformation or collapsing of original responses into a standard format (alco-
hol consumption, health, and physical activity). This involved a more subjective approach: For
example, the division of general health responses into 3 categories for some studies was
informed by the distribution of individuals across categories in the majority of studies (i.e.,
smaller proportions endorsing each of the best and worst health levels than the middle level).
Physical activity was the most difficult factor to harmonize, given the large variety of measures
across the studies, from simple questions on general activity to more involved questionnaires
that specified activities and the frequency and duration these were participated in. Our harmo-
nization protocols for all of the factors, including the specific conditions included in factors
like cardiovascular disease, are fully detailed in S8–S20 Tables.
Statistical analysis
Standardization of outcome scores. First, within each study, raw MMSE and domain
scores, pooled across all waves, were transformed to have a Gaussian (or normal) distribution,
calculated so that the transformed value has the same percentile value as the original value in
the original distribution (in SPSS such scores are described simply as normal scores, but are
produced under the Rank Cases procedure). Transformed score outliers were then winsorized
to values plus or minus 3 standard deviations (SDs) from the mean scores. These were then
standardized by converting to Z-scores within each study, using estimated means and SDs of
baseline scores within each study at common values of age, sex, and education. The common
values were the average values at baseline from data pooled across all studies (common values:
age = 72.7 years, education = 9.0 years, and sex = 0.42, indicating 42% males). SDs used for the
calculation of the Z-scores were the estimated SDs of the residuals (i.e., the standard errors
[SEs] of the estimates) obtained from the regression models for each study after adjustment for
age, sex, and education. Our method of standardizing scores from multiple studies is essentially
the same as that described by Griffith et al. [28] for obtaining standardized demographically
Determinants of cognition in diverse ethno-regional groups
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based category-centered scores. However, instead of obtaining Z-scores using means and SDs
from subsamples within each study with the same restricted ranges of demographic characteris-
tics, we used regression models to obtain estimated means and SDs for specific common values
of demographic variables. The global cognition composite score was computed by averaging the
standardized domain scores, and then standardizing the average scores using the same process
described above. A global cognition composite score was computed for individuals with data
for at least 3 cognitive domains.
Associations of age at baseline, sex, and education with cognitive performance/
decline. Our analyses used linear mixed models, which are widely used to analyze longitudi-
nal data and are recommended to address missing data as well as to reduce non-random attri-
tion bias. Linear mixed models were used to examine the associations of age at baseline, sex,
and education with cognitive performance evaluated at a common value of “time in study”
equal to the mean value for the combined sample, as well as cognitive decline (per decade) on
each outcome, separately for each cohort. These models included fixed effect terms for age at
baseline (centered at the mean of 72.7 years), age at baseline squared, sex (centered at the pro-
portion of 42% males), education (centered at the mean of 9.0 years), time in study (centered
at the mean across all studies of 3.1 years), time in study squared, interactions between age at
baseline and each of education and sex, and interactions between time and each of age at base-
line, sex, and education (the full model equation is displayed in S1 Text). This selection of
model terms was based on preliminary variable selection analyses, such that terms explaining
at least 0.1 percent of variance on at least 1 outcome measure were retained (see S1 Text for
details). The variables were centered to reduce collinearity between the variables and quadratic
or interaction terms. Note that since time in study was centered at 3.1 years, the effects of pre-
dictors on cognition were for performance at this time in study. The intercept and time terms
were treated as random effects, with an unstructured covariance type. Using a method
described by Singer and Willet [29], we investigated the possible influence of baseline perfor-
mance on cognitive decline by examining the covariance between the random effects of inter-
cept and slope. For these analyses, time was coded to have the value 0 at baseline, so that the
covariance term quantifies the relationship between individuals’ performance at baseline and
their rate of change. In the presence of an overall decline in performance over time, a positive
(or negative) covariance term implies that a lower performance at baseline is associated with a
faster (or slower) rate of decline.
Associations between putative risk factors and cognitive performance/decline: Partially
adjusted multivariable models. Associations between each potential risk factor and perfor-
mance/decline for each cognitive outcome were examined using linear mixed models. The
models included the following fixed effect terms: age at baseline, age at baseline squared, edu-
cation, sex, age at baseline × education, the factor being analyzed, time in study, time in study
squared, and 2-way interactions between the factor and each of time in study, time in study
squared, age at baseline, sex, and education (the full model equation is displayed in S1 Text).
Preliminary analyses indicated quadratic associations between cognitive performance and
both education and BMI, consistent with previous reports [30,31]. For this reason, in analyses
where BMI or education were examined, quadratic terms for these were included, as well as
their 2-way interactions with age, age squared, education, sex, time in study, and time in study
squared. Separate linear mixed models were produced for each factor and outcome combina-
tion. The intercept and time terms were included as random terms, with an unstructured
covariance type. While these models investigating risk factors 1 by 1 all included age, sex, and
education, we refer to them as partially adjusted models to distinguish them from later models
featuring multiple risk factors, which are referred to as fully adjusted models.
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We used random effects IPD meta-analysis to pool the cohort-wise linear mixed model
results to obtain pooled estimates of effect sizes for each of the model terms. Of particular
interest were the associations between each factor (including age at baseline, sex, and educa-
tion) and cognitive performance, the association between each factor and cognitive decline
(i.e., the fixed effect of factor × time in study), and the association between each factor and
change in the rate of cognitive decline (i.e., the fixed effect of factor × time in study squared).
A negative pooled value for the factor term would indicate that the factor was associated with a
lower level of cognitive performance at the average time in study of 3.1 years. A negative
pooled value for the time in study term would indicate that cognition declined over time in the
absence of the factor (or at its mean value, for continuous factors). Therefore, a negative
pooled value for the factor × time interaction term would indicate that having the factor was
associated with a faster rate of decline than not having the factor. A significant negative pooled
value for the factor × time in study squared term would indicate that the presence of the factor
is associated with a faster rate of decline with increasing time in study.
Associations between putative risk factors and cognitive performance/decline: Fully
adjusted multivariable models. For each cognitive outcome, we fit multivariable models that
featured multiple factors, and are thus termed fully adjusted, to determine independent associa-
tions with cognitive performance/decline. Not all the factors investigated above were included
in these models as not all were available for every cohort, with the choice of data used involving
a compromise between the number of factors included and the number of cohorts with data for
all factors. The first model (fully adjusted model 1) used data from 11 cohorts (Bambui, EAS,
ESPRIT, HELIAD, HK-MAPS, Invece.Ab, KLOSCAD, PATH, SALSA, SLASI, and Sydney
MAS; N = 13,917) and included alcohol consumption, APOE�4 status, cardiovascular disease,
diabetes, high cholesterol, hypertension, smoking, and history of stroke, as well as age, sex, and
education. Also included were the interactions between each factor and age, age squared, educa-
tion, sex, time in study, and time in study squared. Model terms from within each cohort were
pooled using random effects IPD meta-analysis using the same process described above. This
model was repeated with APOE�4 status replaced with either BMI (using the same cohorts
except for SGS replacing HK-MAPS; N = 17,270) or current depression (using the same cohorts
except for SGS replacing SLASI; N = 18,011). Separate multivariable models were fit because
combining APOE�4, BMI, and current depression in 1 model (either together or in pairs)
meant that the analyses would only include a maximum of 2 cohorts from Asian countries. We
reasoned that a minimum of 3 cohorts from Asian countries was required to perform meaning-
ful comparisons with cohorts of white people (see below). A second fully adjusted model (fully
adjusted model 2) used data from only 9 cohorts (Bambui, EAS, ESPRIT, HELIAD, Invece.Ab,
KLOSCAD, PATH, SALSA, and Sydney MAS; N = 11,897) but simultaneously investigated a
larger set of factors: alcohol consumption, APOE�4 status, BMI, cardiovascular disease, depres-
sion, diabetes, high cholesterol, hypertension, physical activity, smoking, and history of stroke.
Categorical factors with 3 levels were also examined as binary factors by collapsing the higher
levels and comparing against the lowest (e.g., past and current smoking collapsed to ever smok-
ing and compared against never smoked). This allowed for the inclusion of cohorts with only
binary level data on these factors. We report significant results for both the binary and multi-
level versions of each factor, to better understand both the overall and dose–response relation-
ship of a factor’s effects. We also investigated whether baseline cognitive performance was
related to rate of change in each of our fully adjusted models, using the same approach as for
the partially adjusted models described above. Heterogeneity of effect sizes among samples was
assessed using the I2 statistic, reflecting the proportion of variation due to variability between
studies, rather than sampling error or chance. We report I2 values obtained from fixed effects
models, which give appropriate indications of variation across studies. I2 values of<40%,
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40%–60%, and>60% were taken to indicate low, moderate, and substantial heterogeneity,
respectively, as per Cochrane Collaboration guidelines [32].
Ethno-regional comparisons. We examined whether relationships between factors and
cognitive performance/decline differed between groups of white people and Asian people;
included in the white group were all individuals self-reporting or classified as a white person
from 11 cohorts of predominantly white people (CFAS, EAS, ESPRIT, HELIAD, Invece.Ab,
LEILA75+, MAAS, MoVIES, PATH, Sydney MAS, and ZARADEMP), and included in the
Asian group were all individuals from 5 cohorts in countries with majority Asian populations
(HK-MAPS, KLOSCAD, SGS, Tajiri, and SLASI, with the last cohort comprising 95.6% Chi-
nese, 1.8% Malay, 2.1% Indian, and 0.6% other). Individuals from the Latin American and
North American Hispanic cohorts (Bambui, CHAS, SPAH, and SALSA) were not included in
these groups. We performed the partially adjusted and fully adjusted model 1 (including
repeats with BMI or current depression replacing APOE�4 status) linear mixed models
described above using these groups, with the cohort-wise mixed model results pooled and dif-
ferences between white people and Asian people tested using meta-regression. A binary,
cohort-level variable (white person = 0, Asian person = 1) was included as a moderator term in
the meta-regression. A significant moderator term would indicate a significant difference in
the effect between white people and Asian people. Results for model terms were also pooled
within the cohorts of white people or Asian people separately using random effects meta-anal-
ysis. The size, direction, and significance of model terms were examined within each group to
help interpret significant moderator effects.
The Sydney COSMIC team created the pooled dataset and ran the linear mixed models
using IBM SPSS Statistics 24. The meta-analyses were performed using the Metan and Metareg
packages in Stata 13. Two-sided p-values were used, with an α = 0.05 threshold for statistical
significance.
Results
Sample description
The overall sample comprised 48,522 eligible individuals contributed by the 20 cohorts. Their
baseline age ranged from 54 to 105 years (mean = 72.7 ± SD 7.5), and 58.4% were women. The
mean number of years of education was 9.0 (SD = 4.5) years. S21 Table shows cohort-specific
demographic characteristics, and S22 and S23 Tables show the prevalence and mean values for
the factors investigated.
Associations between factors and cognitive performance
Across all 20 cohorts, significant associations were found using both partially and fully
adjusted multivariable models. We focus here on the fully adjusted model results, though later
summarize the partially adjusted model results (full details in S2 Text and S24–S26 Tables). As
shown in Table 2, fully adjusted models identified increased age, APOE�4 carriage, depression,
diabetes, history of stroke, and current smoking as independently associated with lower scores
for 1 or both of the MMSE and global cognition composite. Heterogeneity of these effects was
low (I2 values ranging between 0% and 26.4%), except for age (moderate heterogeneity in
model 2: 56.2%) and APOE�4 carriage (moderate heterogeneity in both models 1 and 2: 48.2%
and 40.2%, respectively). Conversely, cardiovascular disease, higher education, and vigorous
physical activity were associated with better cognitive performance. Heterogeneity for associa-
tions with cardiovascular disease and vigorous physical activity was low across models (I2 <
40%). For education, however, heterogeneity was high in each model (except for MMSE
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performance in model 2). Models replacing APOE�4 status with BMI or current depression
found no associations for these factors (S27 Table).
Associations between factors and cognitive decline
Analyses with no risk factors in the model and pooled across cohorts revealed declining scores
over time for the global cognition composite (B = −0.859, SE = 0.253, p< 0.01) and the MMSE
(B = −0.452, SE = 0.168, p< 0.01; S25 Table). Quadratic effects show the rate of decline per
decade becoming even greater as time in study progressed for the global cognition composite
score (B = −0.049, SE = 0.023, p< 0.05).
Table 2. Associations between putative risk factors and cognitive performance found with fully adjusted modelsa.
Factor Model 1b Model 2c
Global cognition MMSE Global cognition MMSE
B (SE) I2 (%) B (SE) I2 (%) B (SE) I2 (%) B (SE) I2 (%)
Age at baseline −0.091 (0.012)��� 56.2 −0.052 (0.007)��� 35.5 −0.103 (0.013)��� 35.2 −0.060 (0.009)��� 26.7
Education 0.115 (0.021)��� 85.7 0.095 (0.011)��� 71.2 0.126 (0.021)��� 72.2 0.106 (0.010)��� 33.0
Sex, male −0.014 (0.088) 59.7 −0.040 (0.091) 76.8 −0.087 (0.108) 55.5 −0.147 (0.127) 74.5
Alcohol
1 drink/weekd 0.077 (0.108) 0 0.160 (0.085) 0 0.080 (0.113) 0 0.148 (0.087) 0
2+ drinks/weekd 0.081 (0.110) 54.5 0.069 (0.051) 4.6 0.064 (0.111) 52.6 0.063 (0.049) 0
APOE�4 carrier −0.311 (0.107)�� 48.2 −0.006 (0.055) 11.9 −0.251 (0.101)� 40.2 −0.078 (0.049) 0
Body mass indexe 0.001 (0.007) 0 −0.002 (0.006) 23.1
Cardiovascular disease 0.030 (0.058) 0 0.095 (0.044)� 0 0.027 (0.062) 0 0.141 (0.047)�� 0
Depression, current −0.113 (0.057)� 0 −0.073 (0.069) 31.5
Diabetes −0.230 (0.097)� 26.3 −0.119 (0.085) 45.8 −0.209 (0.116) 37.9 −0.136 (0.084) 34.5
High cholesterol −0.034 (0.071) 23.8 −0.034 (0.036) 0 0.012 (0.051) 0 −0.050 (0.039) 0
Hypertension −0.170 (0.115) 64.3 −0.007 (0.044) 7.0 −0.206 (0.122) 61.3 −0.022 (0.044) 0
Physical activity
Moderatef 0.087 (0.093) 28.7 0.069 (0.078) 31.0
Vigorousf 0.160 (0.146) 56.9 0.168 (0.061)�� 0
Smoking
Pastg 0.045 (0.069) 11.2 −0.025 (0.043) 0 0.074 (0.080) 23.0 −0.020 (0.043) 0
Currentg −0.144 (0.170) 34.7 −0.217 (0.082)�� 0 −0.134 (0.167) 33.1 −0.202 (0.082)� 0
History of stroke −0.252 (0.249) 65.9 −0.223 (0.089)� 4.5 −0.218 (0.270) 68.7 −0.199 (0.086)� 0
aResults are for the mean time in study (3.1 years) and controlled for age at baseline (mean = 73.1 years), education (mean = 9.15 years), and sex (40% male); negative B
values indicate worse performance. Global cognition was calculated as a composite of 4 neuropsychological tests, each representing 1 of 4 cognitive domains: memory,
language, processing speed, and executive functioning. MMSE denotes Mini-Mental State Examination. Empty cells are for factors not included in model 1.
�p< 0.05
��p< 0.01
���p< 0.001.
bUsed data from 11 cohorts (N = 13,917) and included alcohol consumption, APOE�4 status, cardiovascular disease, diabetes, high cholesterol, hypertension, smoking,
and history of stroke.
cUsed data from 9 cohorts (N = 11,897) and included alcohol consumption, APOE�4 status, BMI, cardiovascular disease, depression, diabetes, high cholesterol,
hypertension, physical activity, smoking, and history of stroke.
dVersus nil/minimal alcohol.
eCentered at mean = 25.2 kg/m2.
fOne or more times/week versus minimal activity.
gVersus never smoked.
https://doi.org/10.1371/journal.pmed.1002853.t002
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As shown in Table 3, fully adjusted multivariable models found that higher age and
APOE�4 carriage were both associated with more decline on both cognitive outcomes, and
that diabetes was associated with more decline in MMSE score. Cardiovascular disease was
associated with less cognitive decline. Heterogeneity of these associations was low (I2 values
ranging between 0% and 11.1%), except for APOE�4 carriage, for which heterogeneity was
moderate (I2 = 46.6%). Quadratic effects indicated that as time in study progressed, the slower
rate of decline associated with high cholesterol became even slower, whereas the slower rate of
decline associated with alcohol consumption weakened. The faster rate of decline associated
with current smoking also diminished as time progressed (S28 Table). Heterogeneity of these
associations was low (all I2 = 0). Models replacing APOE�4 status with BMI or current depres-
sion found no associations for these factors (S29 and S30 Tables).
Table 4 summarizes the significant linear associations between factors and cognitive perfor-
mance and decline found with partially or fully adjusted multivariable models.
Comparisons of associations between white people and Asian people
Comparisons of associations between white people and Asian people were not performed for
fully adjusted model 2 because this model retained only 1 Asian cohort. Significant results
were found only with partially adjusted models.
Fig 1 shows significant differences in the association of risk factors with cognitive perfor-
mance between white people and Asian people. Global cognition composite scores for men
were lower than for women in white people but higher than for women in Asian people
(group difference: B = 0.334, SE = 0.085, p< 0.001). Moderate heterogeneity for this effect
(I2 = 54.9) suggests that the effect was not fully accounted for by ethno-regional differences.
For the MMSE, APOE�4 carriers had higher scores than non-carriers in Asian people but not
in white people (group difference: B = 0.343, SE = 0.146, p< 0.05). Poor self-rated health was
associated with lower MMSE scores in white people but not in Asian people (group difference:
B = 0.266, SE = 0.12, p< 0.05). Compared to white people, Asian people showed greater nega-
tive effects on MMSE scores associated with ever smoking (B = −0.240, SE = 0.118, p< 0.05).
Heterogeneity for the effects of APOE�4 carriage, poor self-rated health, and smoking was low
(I2 range = 0%–8.8%), suggesting that ethno-regional differences played a considerable role.
For full results, including within-group effects, see S31 Table.
The overall rate of cognitive decline did not differ between white people and Asian people
(see the results for models featuring no risk factors in S32 Table). However, the trajectories for
MMSE scores associated with some factors differed significantly between white people and
Asian people, as shown in Fig 2. There was greater decline associated with diabetes for Asian
people than for white people (B = −0.658, SE = 0.27, p< 0.05; S32 Table). Further, quadratic
effects showed that with increasing time in study, there was a growing rate of decline associated
with each of diabetes (B = −0.296, SE = 0.137, p< 0.05), high cholesterol (B = −0.296,
SE = 0.132, p< 0.05), and higher education (B = −0.024, SE = 0.011, p< 0.05) among Asian
people compared to white people (S33 Table). Heterogeneity for each of these group differences
was low (I2 < 10%), again suggesting a substantial influence of ethno-regional differences.
Discussion
This large meta-analysis of over 48,000 individuals from 15 countries investigated associations
between putative risk factors and late-life cognition. It has an additional 6 cohorts (including
from 3 new countries) relative to our earlier study of cognitive decline in COSMIC cohorts
[5], but more importantly includes a wide range of risk factors, beyond only those of age, sex,
education, and APOE�4 carriage that we previously investigated. The current study found that
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higher age showed negative associations with performance and decline, in keeping with age
being the strongest risk factor for dementia [33], and also for mild cognitive impairment [34].
Other factors independently associated with poorer performance were APOE�4 carriage,
depression, diabetes, current smoking, and history of stroke. APOE�4 carriage and diabetes
were also both independently associated with cognitive decline. Associations of cognitive per-
formance and decline with APOE�4 reflect its being a risk factor for Alzheimer disease [35],
and the corresponding moderate levels of heterogeneity are consistent with the relationship
between APOE�4 and dementia being influenced by factors we did not control for in these
analyses, such as race/ethnicity (which was controlled only in later analyses) and midlife
Table 3. Effects of putative risk factors on the rate of cognitive decline found with fully adjusted modelsa.
Factor Model 1b Model 2c
Global cognition MMSE Global cognition MMSE
B (SE) I2 (%) B (SE) I2 (%) B (SE) I2 (%) B (SE) I2 (%)
Age at baseline −0.065 (0.005)��� 0 −0.046 (0.005)��� 18.2 −0.067 (0.006)��� 0 −0.051 (0.005)��� 0
Education −0.017 (0.011) 56.3 0.002 (0.008) 39.4 −0.024 (0.013) 62.9 0 (0.009) 39.7
Sex, male 0.016 (0.074) 37.7 0.025 (0.075) 50.0 0.003 (0.079) 38.0 −0.072 (0.048) 0
Alcohol
1 drink/weekd 0.254 (0.304) 57.8 0.121 (0.090) 0 0.137 (0.286) 49.8 0.155 (0.094) 0
2+ drinks/weekd 0.120 (0.140) 43.1 0.009 (0.083) 28.6 0.055 (0.162) 49.9 −0.003 (0.09) 36.6
APOE�4 carrier −0.339 (0.143)� 38.8 −0.103 (0.078) 24.3 −0.409 (0.177)� 49.6 −0.167 (0.077)� 17.5
Body mass indexe −0.014 (0.009) 0 0.003 (0.012) 52.8
Cardiovascular disease 0.140 (0.077) 0 0.156 (0.071)� 8.9 0.169 (0.083)� 0 0.182 (0.067)�� 0
Depression, current 0.033 (0.220) 47.2 −0.03x (0.103) 30.8
Diabetes −0.010 (0.100) 0 −0.128 (0.126) 45.7 −0.012 (0.108) 0 −0.185 (0.091)� 11.1
High cholesterol 0.074 (0.065) 0 −0.080 (0.052) 0 0.094 (0.070) 0 −0.048 (0.083) 30.8
Hypertension −0.156 (0.177) 57.7 0.058 (0.051) 0 −0.114 (0.179) 46.9 0.065 (0.056) 0
Physical activity
Moderatef 0.033 (0.096) 0 0.123 (0.124) 47.0
Vigorousf 0.039 (0.160) 26.6 0.058 (0.092) 13.7
Smoking
Pastg −0.096 (0.073) 0 −0.007 (0.089) 40.1 −0.069 (0.085) 7.1 −0.009 (0.088) 39.5
Currentg −0.084 (0.220) 11.7 −0.090 (0.183) 46.4 −0.051 (0.244) 17.0 −0.090 (0.183) 46.4
History of stroke −0.280 (0.177) 0 −0.136 (0.243) 62.2 −0.239 (0.217) 8.8 −0.278 (0.154) 20.4
Baseline score −0.030 (0.050) 41.8 0.007 (0.046) 69.7 0.002 (0.036) 13.0 0.014 (0.039) 53.1
aFactor × time interactions for the mean time in study (3.1 y), controlled for age at baseline (mean = 73.1 y), education (mean = 9.15 y), and sex (40% female); negative B
values indicate more decline. Global cognition was calculated as a composite of 4 neuropsychological tests, each representing 1 of 4 cognitive domains: memory,
language, processing speed, and executive functioning. MMSE denotes Mini-Mental State Examination. Empty cells are for factors not included in model 1.
�p< 0.05
��p< 0.01
���p< 0.001.
bUsed data from 11 cohorts (N = 13,917) and included alcohol consumption, APOE�4 status, cardiovascular disease, diabetes, high cholesterol, hypertension, smoking,
and history of stroke.
cUsed data from 9 cohorts (N = 11,897) and included alcohol consumption, APOE�4 status, BMI, cardiovascular disease, depression, diabetes, high cholesterol,
hypertension, physical activity, smoking, and history of stroke.
dVersus nil/minimal alcohol.
eCentered at mean = 25.2 kg/m2.
fOne or more times/week versus minimal activity.
gVersus never smoked.
https://doi.org/10.1371/journal.pmed.1002853.t003
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vascular risk factors [36,37]. Evidence also links diabetes with poorer cognitive performance
and greater decline [38], as well as increased risk of dementia [39]. The relationship between
late-life depression and cognitive dysfunction is complex [40], but our finding of an associa-
tion with performance but not decline might favor late-life depression being a psychological
response to cognitive impairment or a prodrome of dementia, rather than a causal factor. Cog-
nitive outcomes following stroke are varied [41], and our finding of stroke being indepen-
dently associated with poorer performance but not decline suggests greater effects of stroke on
initial impairment than on more gradual later changes in cognition. While implicated as a risk
factor for cognitive decline and dementia [42], we found current smoking to be associated
with a slowing of the rate of decline over time. This might reflect a protective effect of nicotine
or smoking in late-life on cognition [43], or a selection bias arising from the death or dropout
of smokers experiencing detrimental health or cognitive effects. Smokers had poorer cognitive
performance than non-smokers, consistent with an overall negative cumulative impact of
smoking on late-life cognition [44].
Education and vigorous physical activity were both independently associated with better
cognitive performance. The association for education is well established [45], but our
Table 4. Summary of factors significantly associated with worse or better cognitive performance and/or faster or
slower cognitive declinea.
Factor Performance Decline
Worse performance or faster decline
Age at baseline Global; MMSE Global; MMSE
Anxietyb Global
APOE�4 carriage Global Global; MMSE
Body mass index Global
Depression, current Global; MMSE
Diabetes Global; MMSE MMSE
Health, poorb,c Global; MMSE Global
Hypertension Global
Peripheral vascular disease Global
Smoking, current Global
Smoking, past Global
Stroke Global; MMSE Global; MMSE
Better performance or slower decline
Alcohol, 1 drink/weekd MMSE
Alcohol, 2+ drinks/weekd MMSE MMSE
Cardiovascular disease MMSE Global; MMSE
Education Global; MMSE
Physical activity, vigorouse Global; MMSE
aSignificant effects for at least 1 fully adjusted multivariable model (independent effects) are shown in bold font, and
significant effects for only partially adjusted multivariable models are in normal font. Empty cells indicate no
significant results. Global cognition was calculated as a composite of 4 neuropsychological tests, each representing 1
of 4 cognitive domains: memory, language, processing speed, and executive functioning. MMSE denotes Mini-
Mental State Examination.
bNot included in fully adjusted models.
cVersus very good.
dVersus nil/minimal alcohol.
eOne or more times/week versus minimal activity.
https://doi.org/10.1371/journal.pmed.1002853.t004
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Fig 1. Risk factors for cognitive performance that differ between Asian people and white people. Bars show standardized scores at the mean time in study (3.1 years)
for participants with and without the risk factor in both groups: Asian people and white people. Error bars indicate standard error of the mean. Mean Mini-Mental State
Examination (MMSE) performance is compared for smokers and non-smokers (A), participants with poor versus very good self-rated health (B), and apolipoprotein E
ε4 allele (APOE�4) carriers and non-carriers (C). (D) compares the mean performance for the global cognition composite (calculated from tests of 4 cognitive domains)
in men and women.
https://doi.org/10.1371/journal.pmed.1002853.g001
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observation of high heterogeneity in the association between education and cognition across
cohorts is consistent with a previously reported large degree of ethno-geographic variability in
the association between education and dementia [46]. While existing evidence supports a posi-
tive effect of physical activity on cognition [47], we found that vigorous physical activity was
associated with better cognition, but that moderate activity was not. However, we did not dis-
tinguish between moderate intensity activity types or consider duration or frequency beyond
at least once a week. The association between physical activity and cognition was independent
of potential mediating factors like BMI and cardiovascular disease, consistent with more direct
neuroplastic effects [47]. Cardiovascular disease was associated with better cognitive perfor-
mance and slower decline. This differs from reports of the opposite association [48] or of no
association in individuals aged 65 years or more [49]. While this result remains unaccounted
for, the true association may have been obscured by not controlling for the potentially protec-
tive effects of medications [50]. Our results for high cholesterol are consistent with this being
associated with a lower risk of dementia [51] and less cognitive decline in late life [52].
Atrial fibrillation is often reported as a risk factor for cognitive decline [53], but this associa-
tion was not observed in the current study. From another study, the risk of cognitive decline
appears to be stronger with earlier age of onset and longer duration of atrial fibrillation [54],
but we did not have age of onset data to gauge whether participants in our cohorts had atrial
fibrillation long enough to elicit statistically significant effects. We also did not have the data
needed to consider the use of anticoagulants, which a recent meta-analysis found significantly
reduced the effects of atrial fibrillation on cognitive decline [55].
Global cognition composite scores for men were lower than for women among white peo-
ple, but this was reversed in Asian people. Older women generally outperform older men on
verbal memory tests, possibly because of biological mechanisms such as effects of estrogen
[56] or sex-specific cognitive reserve [57], but also sociocultural factors [58]. Opposite effects
have been attributed to gender disparities in educational opportunities and socioeconomic
investment in some countries, including China [59]. Indeed, another study from China found
better memory performance in women than men when levels of education were comparable
[60]. Our observation of a moderate level of heterogeneity for ethno-regional differences in the
association between sex and cognition supports the idea that factors like socioeconomics may
be involved, but that these are not ethno-regionally specific. APOE�4 carriers had higher
MMSE scores than non-carriers among Asian people, but not among white people. The low
heterogeneity of this difference suggests that ethno-regional differences played a large role in
accounting for the moderate level of between-study variability of this effect when investigated
across all cohorts (Table 2). While some studies report better performance on particular cogni-
tive tests among carriers [61], higher scores are not expected, given the association between
APOE�4 and Alzheimer disease [35]. However, the prevalence of APOE�4 among individuals
with Alzheimer disease is reportedly lower in Asian countries than in North America and
Northern Europe [62]. This potentially suggests APOE�4 has less detrimental cognitive effects
in Asian people, but does not explain better scores. APOE�4 is a strong predictor of mortality
[63], and differences in this association between white people and Asian people that could gen-
erate different levels of survivor bias in these groups remain to be explored. Lower cognitive
performance in white people with poor self-rated health is consistent with expectations [64].
Fig 2. Risk factors for cognitive decline that differ between Asian people and white people. Fitted trajectories are
for the first half decade since baseline, and show mean changes in standardized Mini-Mental State Examination
(MMSE) scores for both groups: Asian people and white people. (A) compares participants with and without high
cholesterol, and (B) compares participants with and without diabetes. (C) compares participants with high and low
levels of education, determined as 1 standard deviation (4.5 years) above and below the mean of 9 years, respectively.
https://doi.org/10.1371/journal.pmed.1002853.g002
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However, Asian people with poor self-rated health did not show worse cognition, possibly
because culturally based health perceptions led them to underestimate their true health status,
as suggested by the finding that US residents of Asian ethnicity (~80% foreign-born) more
often report poor or fair health than US-born white people, despite having objectively better
health [65]. Ever smoking had larger negative effects on MMSE scores in Asian people than in
white people. While this effect is potentially related to differences in the lifetime duration and
intensity of smoking [44], we lack sufficient data to investigate this.
Compared to white people, there was both more cognitive decline and a growing rate of
decline associated with diabetes in Asian people, who might develop diabetes younger and
experience more complications than people of European descent [66]. We also found a grow-
ing rate of cognitive decline associated with high cholesterol in Asian people. A previous find-
ing of faster cognitive decline in Chinese participants with high cholesterol was thought to
potentially reflect ethnic/racial differences and/or a low use of statins, which may convey cog-
nitive benefits [67]. Similar effects could help to explain our results, given a report of lower
statin use among outpatients with atherothrombosis in Asian countries (including all that we
investigated) than in North America, Western Europe, and Australia [68]. The cognitive
reserve hypothesis suggests that education delays cognitive decline by offsetting the effects of
accumulating neuropathology, but that decline is rapid once the level of neuropathology can-
not be compensated for [69]. The growing rate of cognitive decline associated with increased
education among Asian people compared to white people might be because white people had
higher levels of education overall, and did not show an association between education and
decline at the mean age of study because of greater cognitive reserve.
The results of this study show similarities with and differences from our earlier study using 14
COSMIC cohorts [5]. However, it is important to note that the focuses of the studies were slightly
different, and the corresponding differences in the statistical approaches mean that the results
from the 2 studies are not strictly comparable. Our earlier study focused on modeling the trajec-
tory of variation of cognitive performance with age, combining both cross-sectional and longitu-
dinal variation of cognition with age, whereas the current study made time in study the main
predictor variable (and included age at baseline as a covariate). The latter approach distinguishes
between the effects of cross-sectional and longitudinal variation of age, and is similar to that used
by Piccinin et al. [70]. Faster decline with greater age, or with longer time in study, and APOE�4
carriage was found in both COSMIC studies, but only the earlier study found slightly slower
decline on the MMSE with more education or being male, and slightly faster decline on the
MMSE for Asian people than for white people. The addition of new cohorts and change in over-
all ethno-regional representation may have also contributed to these differences, as could have
the slightly greater overall level of education of the participants in the current study (9.0 versus
8.8 years), given how education can affect decline via cognitive reserve as discussed above.
Our study has a number of limitations, including the broad classifications of people as
white or Asian that overlook major ethnic and genetic diversity. We aim to expand the number
of COSMIC members from particular countries to enable us to perform analyses with more
refined groups, such as Chinese or Japanese rather than Asian people more broadly, in future
investigations. Harmonization of data can involve some loss or distortion of information that
may alter the nature of associations found. This may be particularly so for physical activity,
where the nuances of questionnaires used by some studies were lost during harmonization to a
simpler format that accommodated data from studies with less sophisticated measures. Other
limitations include insufficient anxiety and general health data to investigate any independent
associations of these factors with cognition. All of the factors we investigated have been previ-
ously linked to cognitive performance or decline, but so have others not included in the cur-
rent study, including hearing loss and social isolation [71]. We intend to investigate these
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factors in the future, using different and smaller sets of COSMIC cohorts that have these data.
Further, we did not specifically investigate factors at midlife, when some, such as high choles-
terol, exert their strongest late-life cognitive effects [72]. The MMSE has been criticized as psy-
chometrically unsound for assessing cognitive change in healthy older adults [73], and its
having different properties from our global cognition composite may explain some of the dif-
ferent findings between these measures. Also, only using global measures of cognition means
effects of factors associated with particular cognitive domains were not investigated. Finally,
across all factors investigated, we found more to be associated with cognitive performance
than with cognitive decline. This suggests that many of the associations may be due to com-
mon or confounding causes rather than the identified factors having causal effects on cognitive
change in late life.
In this study, we identified factors with independent effects on late-life cognitive perfor-
mance and decline. With data from so many diverse international cohorts, our results can be
generalized on a global scale. Some of the factors we identified are modifiable, including edu-
cation, smoking, physical activity, diabetes, and stroke. However, since this analysis cannot
establish causality, the utility of targeting these factors in interventions to delay or minimize
cognitive decline, including that leading to dementia, is unknown. It was recently reported
that some dementia risk factors are more prevalent in low- and middle-income countries than
in high-income countries, which contributes to them having greater population attributable
fractions for dementia in those regions [74]. This, together with our finding that white people
and Asian people showed different associations between some factors and cognition, suggests
that interventions to reduce the risk and level of cognitive decline and dementia may require
tailoring to particular ethno-regional groups. Further consideration of how interventions are
implemented is likely to be particularly required in low- and middle-income countries, where
resources may be limited and access to healthcare restricted [75].
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